ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01405820
Brief Title: Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS) (REFINE)

First Submitted : July 14, 2011
First Submitted that Met QC Criteria : July 28, 2011
First Posted : July 29, 2011 (Estimate)

Results First Submitted : June 29, 2015
Results First Submitted that Met QC Criteria : June 29, 2015
Results First Posted : July 29, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : August 3, 2015
Last Update Posted : August 21, 2015 (Estimate)